E78.0 G60.1 E78.1 E78.2 E78.3 E78.4 E78.5 E78.8 E78.9
Conditions
Interventions
Group 1: The data of patients with the indication of lipoprotein apheresis are documented:
Retrospective part:
• Before the onset of lipoprotein apheresis treatment
(e.g., lipid parameters, mutations, first cardiovascular manifestations, or other disease-specific manifestations and symptoms, events and interventions, relevant adjunctive diseases, medication).
Pr
Sponsors
Apherese Forschungsinstitut
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: In the case of the patients examined in the context of this documentation, the indication for lipoprotein apheresis exists. The patients covered in this documentation are routinely treated within the contractual medical care of lipoprotein apheresis. General inclusion / exclusion criteria: • The respondent is in a position to give his / her informed consent to study participation after elucidation. • Male and female subjects, age = 18 years.
Exclusion criteria
Exclusion criteria: The following criteria lead to the exclusion / withdrawal of the study for the person concerned: • The subject withdraws his consent. • Any medical or non-medical reason which, in the opinion of the examiner, requires the completion of the documentation for the subject. • The investigation can be terminated at the beginning at any time by the sponsor or the director of the documentation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Documentation of the efficacy of lipoprotein apheresis in different indications; Clinical and laboratory parameters. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Effectiveness of lipoprotein apheresis by clinical parameters (e.g., occurrence of cardiovascular events, course of disease-specific symptoms) • Documentation of safety and tolerability using reference apheresis treatments • documentation of disease-specific laboratory parameters before, during and after therapy (e.g., LDL cholesterol, lipoprotein(a), triglycerides) | — |
Countries
Germany
Contacts
Public ContactReinhard Klingel
Apherese Forschungsinstitut
Outcome results
None listed